Journal of Applied Physiology, Vol 73, Issue 3 1093-1101, Copyright © 1992 by American Physiological Society

ARTICLES

Immunologic mast cell-mediated responses and histamine release are attenuated by heparin

J. Lucio, J. D'Brot, C. B. Guo, W. M. Abraham, L. M. Lichtenstein, A. Kagey-Sobotka and T. Ahmed
Division of Pulmonary Disease, Mount Sinai Medical Center, University of Miami School of Medicine, Miami Beach, Florida 33140.

Heparin has been shown to act as a competitive inhibitor of inositol 1,4,5-triphosphate (InsP3) receptors in various cell types. Because InsP3 is one of the second messengers involved in stimulus-secretion coupling in mast cells, it is possible that heparin may inhibit mast cell-mediated reactions. Therefore, in allergic sheep, we tested this hypothesis in two mast cell-mediated reactions induced by immunologic and nonimmunologic stimuli: immediate cutaneous reaction (ICR) and acute bronchoconstrictor response (ABR). In 12 sheep allergic to Ascaris suum antigen, the surface area of the skin wheal was determined 20 min after intradermal injection (0.05 ml) of increasing concentrations of specific antigen, compound 48/80, and histamine, without and after pretreatment with heparin (100, 300, or 1,000 U/kg i.v.). Antigen, compound 48/80, and histamine produced concentration-dependent increases in ICR. Heparin "partially" inhibited the ICR to antigen and compound 48/80 in a dose-dependent manner without modifying the ICR to histamine. The heparin preservative benzyl alcohol was ineffective. In 11 additional sheep, specific lung resistance was measured before and after inhalation challenges with antigen, compound 48/80, and histamine without and with aerosol heparin pretreatment (1,000 U/kg). Heparin blocked the antigen- and compound 48/80-induced bronchoconstriction without modifying the airway effects of histamine. In isolated human uterine mast cells, heparin inhibited the anti-immunoglobulin E- but not the calcium ionophore- (A23187) induced histamine release. These data suggest that heparin inhibits the ICR and ABR induced by stimuli that produce immunologic and nonimmunologic mast cell degranulation without attenuating the effects of histamine.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Nahrendorf, E. Aikawa, J.-L. Figueiredo, L. Stangenberg, S. W. van den Borne, W. M. Blankesteijn, D. E. Sosnovik, F. A. Jaffer, C.-H. Tung, and R. Weissleder Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction Eur. Heart J., February 2, 2008; 29(4): 445 - 454. [Abstract] [Full Text] [PDF]

				B. Echtenacher, K. Weigl, N. Lehn, and D. N. Mannel Tumor Necrosis Factor-Dependent Adhesions as a Major Protective Mechanism Early in Septic Peritonitis in Mice Infect. Immun., June 1, 2001; 69(6): 3550 - 3555. [Abstract] [Full Text] [PDF]

				R. SUZUKI and A. N. FREED Heparin Inhibits Eicosanoid Metabolism and Hyperventilation-induced Bronchoconstriction in Dogs Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1850 - 1854. [Abstract] [Full Text]

				T. AHMED, B. J. GONZALEZ, and I. DANTA Prevention of Exercise-induced Bronchoconstriction by Inhaled Low-molecular-weight Heparin Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 576 - 581. [Abstract] [Full Text]

				C. Campo, J. F. Molinari, J. Ungo, and T. Ahmed Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses J Appl Physiol, February 1, 1999; 86(2): 549 - 557. [Abstract] [Full Text] [PDF]

				J. F. MOLINARI, C. CAMPO, S. SHAKIR, and T. AHMED Inhibition of Antigen-induced Airway Hyperresponsiveness by Ultralow Molecular-weight Heparin Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 887 - 893. [Abstract] [Full Text] [PDF]

				J. Martinez-Salas, R. Mendelssohn, W. M. Abraham, B. Hsiao, and T. Ahmed Inhibition of allergic airway responses by inhaled low-molecular-weight heparins: molecular-weight dependence J Appl Physiol, January 1, 1998; 84(1): 222 - 228. [Abstract] [Full Text] [PDF]

				T. Ahmed, J. Garrigo, and I. Danta Preventing Bronchoconstriction in Exercise-Induced Asthma with Inhaled Heparin N. Engl. J. Med., July 8, 1993; 329(2): 90 - 95. [Abstract] [Full Text]